Stocks to buy

Will neo-banking firm SoFi Technologies (NASDAQ:SOFI) be the comeback story of 2023? SOFI stock has several potential turnaround drivers that last year’s downtrodden investors can look forward to this year. As you’re surely aware, last year’s inflation woes and recession fears prompted a selloff in the stock market. SoFi’s investors were hit with staggering losses, but
0 Comments
With the recent bull run among stocks (especially among riskier, more speculative plays), you may be looking to deploy more capital into the market. Yet while the “hottest” stocks out there today may look like tempting stocks to buy, you may want to set your sights on higher-quality plays instead. Why? For starters, it’s unclear
0 Comments
The rise of AI stocks as a key investing trend is notable. Whether we’re talking about ChatGPT or other incredible applications of artificial intelligence technology, it’s clear there’s plenty of disruption on the horizon in this space. Of course, plenty of AI companies have popped up, aimed at different segments of the market. Some are focused on
0 Comments
What’s in store for China-based electric vehicle (EV) manufacturer Nio (NYSE:NIO) in 2023? The company has a lot to prove this year but also has strong momentum in its vehicle deliveries. As Nio prepares to roll out new vehicle models, prospective NIO stock investors should take notice but shouldn’t jump into the trade until the price
0 Comments
[Editor’s note: “It’s the Perfect Time to Buy Amazon Stock” was previously published in January 2023. It has since been updated to include the most relevant information available.] I’m no long-term fan of Big Tech stocks. Earlier last year, I made the bold claim that Big Tech stocks were dead, calling for the demise of
0 Comments
CRISPR technology has the potential to revolutionize the way we approach medicine. This technology has already been used in a variety of applications, including gene editing, gene therapy, and disease diagnosis. As a result, companies developing CRISPR-based products and services have seen significant valuation growth since inception, with many CRISPR stocks having excellent long-term upside
0 Comments